News

EMA Expresses No Significant Concerns About Sputnik V Production or Clinical Trials, RDIF Says
04.06.2021 EMA Expresses No Significant Concerns About Sputnik V Production or Clinical Trials, RDIF Says

ST. PETERSBURG (Sputnik) - The European Medicines Agency (EMA), which is currently studying Russia's Sputnik V vaccine against COVID-19...

Russian Ambassador: SputnikV efficacy at 91.8% in elderly, EU to examine vaccine this month
01.06.2021 Russian Ambassador: SputnikV efficacy at 91.8% in elderly, EU to examine vaccine this month

The first Russian vaccine against COVID-19, SputnikV, named after the first artificial space satellite in history, has been approved so far in 23 countries...

Sputnik V vaccine has 91.6% efficacy against symptomatic Covid, Russian trial suggests
01.05.2021 Sputnik V vaccine has 91.6% efficacy against symptomatic Covid, Russian trial suggests

The Sputnik V vaccine, which has been the subject of scepticism since Russia began using it last year before trials had ended, is 91.6% effective..

Innovative Solutions
For A Healthy Life

Contact us;
info@viscoranilac.com